Ibaraki, Japan

Yorohisa Hoshino

This inventor holds 1 USPTO granted patent. Top assignee: Eisai Company, Limited. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yorohisa Hoshino. Retrieved from https://idiyas.com/inventor/yorohisa-hoshino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yorohisa Hoshino

Introduction

Yorohisa Hoshino is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of chemistry, particularly in the development of aminobenzoic acid derivatives. His work focuses on compounds that exhibit serotonin antagonism and enhance acetylcholine release.

Latest Patents

Hoshino holds a patent for aminobenzoic acid derivatives. This patent aims to provide a compound that demonstrates a well-balanced activity ratio of serotonin antagonism and acetylcholine release acceleration. The compound is represented by specific general formulas, which include various functional groups that enhance its pharmacological properties.

Career Highlights

Hoshino is associated with Eisai Company, Limited, where he continues to innovate in the pharmaceutical sector. His research has the potential to impact treatments related to neurological conditions, showcasing his commitment to advancing medical science.

Collaborations

Hoshino has worked alongside talented colleagues such as Shuhei Miyazawa and Hisashi Shibata. Their collaborative efforts contribute to the innovative environment at Eisai Company, Limited.

Conclusion

Yorohisa Hoshino's work in developing aminobenzoic acid derivatives highlights his role as a significant inventor in the pharmaceutical industry. His contributions are paving the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…